RIP2 kinase inhibitor 1
|
|
|
- CAS號:
- 1423186-80-4
- 英文名:
- RIP2 kinase inhibitor 1
- 英文別名:
- CS-5912;RIPK2-IN-1;RIP2 kinase inhibitor 1;GSK2983559 active metabolite;RIP2 kinase inhibitor GS2983559;GSK2983559 active metabolite ，E2822;GSK2983559 active metabolite, 10 mM in DMSO;2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethan-1-ol;Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-;RIPK,Inhibitor,RIP kinase,GSK2983559 active metabolite,Receptor-interacting protein kinases,inhibit,GSK-2983559 active metabolite
- 中文名:
- RIP2 kinase inhibitor 1
- 中文別名:
- 化合物GSK2983559;化合物GSK2983559,10 MM DMSO 溶液;GSK2983559 active metabolite 試劑;GSK2983559 active metabolite 試劑;GSK2983559 active metabolite ,E2822;2-[4-(5-苯并噻唑氨基)-6-[(1,1-二甲基乙基)磺酰基]-7-喹唑啉基]氧基乙醇;2-((4-(苯并[D]噻唑-5-基氨基)-6-(叔丁基磺?；?喹唑啉-7-基)氧基)乙-1-醇
- CBNumber:
- CB03146619
- 分子式:
- C21H22N4O4S2
- 分子量:
- 458.55
- MOL File:
- 1423186-80-4.mol
|
|
|
RIP2 kinase inhibitor 1化學性質
-
沸點:
-
719.9±60.0 °C(Predicted)
-
|
-
密度:
-
1.423±0.06 g/cm3(Predicted)
-
|
-
儲存條件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO:5.0(Max Conc. mg/mL);9.28(Max Conc. mM)
-
|
-
形態(tài):
-
Solid
-
|
-
酸度系數(pKa):
-
13.82±0.10(Predicted)
-
|
-
顏色:
-
Light yellow to yellow
-
|
RIP2 kinase inhibitor 1性質、用途與生產工藝
GSK2983559 active metabolite 是 GSK2983559 的活性代謝物。GSK2983559 active metabolite 是一種受體相互作用蛋白-2 (RIP2) 激酶抑制劑，詳細信息請參考專利 WO/2014043446 A1 中的化合物 example 1。
RIP2 kinase inhibitor 1
上下游產品信息
上游原料
下游產品
| 更新日期 | 產品編號 | 產品名稱 | CAS編號 | 包裝 | 價格 |
|---|
| 2026/06/05 | HY-19764 | RIP2 kinase inhibitor 1
GSK2983559 active metabolite | 1423186-80-4 | 1mg | 516元 |
| 2026/06/05 | HY-19764 | RIP2 kinase inhibitor 1
GSK2983559 active metabolite | 1423186-80-4 | 5mg | 1200元 |
RIP2 kinase inhibitor 1
生產廠家
RIP2 kinase inhibitor 1 圖譜信息:
1423186-80-4, RIP2 kinase inhibitor 1 相關搜索:
- 抑制劑
- GSK2983559 active metabolite 試劑
- GSK2983559 active metabolite 試劑
- GSK2983559 active metabolite ,E2822
- 化合物GSK2983559,10 MM DMSO 溶液
- 2-((4-(苯并[D]噻唑-5-基氨基)-6-(叔丁基磺?；?喹唑啉-7-基)氧基)乙-1-醇
- 2-[4-(5-苯并噻唑氨基)-6-[(1,1-二甲基乙基)磺?；鵠-7-喹唑啉基]氧基乙醇
- 化合物GSK2983559
- 1423186-80-4
- GSK2983559 active metabolite ，E2822
- GSK2983559 active metabolite, 10 mM in DMSO
- 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethan-1-ol
- RIPK,Inhibitor,RIP kinase,GSK2983559 active metabolite,Receptor-interacting protein kinases,inhibit,GSK-2983559 active metabolite
- Ethanol, 2-[[4-(5-benzothiazolylamino)-6-[(1,1-dimethylethyl)sulfonyl]-7-quinazolinyl]oxy]-
- RIP2 kinase inhibitor GS2983559
- GSK2983559 active metabolite
- RIPK2-IN-1
- CS-5912
- RIP2 kinase inhibitor 1